1Y Close · As of Aug 26, 2026
HLB bioStep operates in the Professional Services sector.
Legal name: HLB bioStep Co.,Ltd.
In fiscal year 2025, HLB bioStep (278650) reported revenue of 74.1 billion KRW, up 27.3% from 58.2 billion KRW a year earlier.
Operating profit was -8.6 billion KRW and net income was -20.3 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 40.4 billion KRW, with a P/B of 0.40.
These figures can be verified in the DART filing (receipt no. 20260318001696).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 74.1B | -8.6B | -20.3B |
| 2024 | 58.2B | -13.0B | -9.7B |
| 2023 | 52.8B | -1.3B | -54M |
Checks
2 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: Treasury stock filings in the last 3 years: 1 disposal(s).
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-27 | Officer/Major Shareholder Ownership Report |
| 2026-08-14 | Semi-Annual Report (2026.06) |